Ads

 

Ads

 

Ads

 

World Top 100 Healthcare Companies List by Market Cap in January 2024

World Top 100 Healthcare Companies List by Market Cap in January 2024, World Biggest 100 Healthcare Companies by Market Cap, World Largest 100 Healthcare Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Healthcare Companies in 2024
Metatag Abstract
World Top Healthcare Companies by Market Cap in 2024, World Top Healthcare Companies by Market Cap in 2024.
  1. Bellus Health

    World Rank (Jan-05-2024)
    5,990
    World Rank (Jul-30-2023)
    5,990
    Market Cap (Jul-30-2023)
    1.870 Billion USD
    World Rank (Dec-25-2022)
    7,834
    Market Cap (Dec-25-2022)
    1.121 Billion USD
    World Rank (Jan-07-2022)
    11,402
    Market Cap (Jan-07-2022)
    0.71 Billion USD
    Headquarters Country
    Company Profile

    BELLUS Health is developing BLU-5937, a P2X3 antagonist, to help people with chronic cough and other afferent hypersensitization-related disorders. Headquarters is in Canada.

  2. Yipinhong Pharmaceutical

    World Rank (Jan-05-2024)
    5,991
    Market Cap (Jan-05-2024)
    1.838 Billion USD
    World Rank (Jul-30-2023)
    6,307
    Market Cap (Jul-30-2023)
    1.721 Billion USD
    World Rank (Dec-25-2022)
    7,017
    Market Cap (Dec-25-2022)
    1.351 Billion USD
    World Rank (Jan-07-2022)
    7,265
    Market Cap (Jan-07-2022)
    1.57 Billion USD
    Headquarters Country
  3. Shanghai Shyndec Pharmaceutical

    World Rank (Jan-05-2024)
    6,008
    Market Cap (Jan-05-2024)
    1.825 Billion USD
    World Rank (Jul-30-2023)
    5,635
    Market Cap (Jul-30-2023)
    2.051 Billion USD
    World Rank (Dec-25-2022)
    7,020
    Market Cap (Dec-25-2022)
    1.350 Billion USD
    World Rank (Jan-07-2022)
    7,117
    Market Cap (Jan-07-2022)
    1.63 Billion USD
    Headquarters Country
  4. Catalyst Pharmaceuticals

    World Rank (Jan-05-2024)
    6,011
    Market Cap (Jan-05-2024)
    1.824 Billion USD
    World Rank (Jul-30-2023)
    6,873
    Market Cap (Jul-30-2023)
    1.501 Billion USD
    World Rank (Dec-25-2022)
    5,484
    Market Cap (Dec-25-2022)
    1.978 Billion USD
    World Rank (Jan-07-2022)
    11,623
    Market Cap (Jan-07-2022)
    0.68 Billion USD
    Annual Revenue in USD
    214 Million USD
    Annual Operating Income in USD
    101 Million USD
    Annual Net Income in USD
    83 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Catalyst Pharmaceuticals is a Biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating neuromuscular and neurological diseases. The headquarters is in USA.

    Facts About Company

    Catalyst Pharmaceuticals Annual Total Revenue for year ending Dec-2022 was 214 million USD and and Net Income for year ending Dec-2022 was 83 million USD.

    Catalyst Pharmaceuticals Annual Total Revenue for year ending Dec-2021 was 140 million USD and and Net Income for year ending Dec-2021 was 39 million USD.

    As on 2022, Catalyst Pharmaceuticals has 82 employees.

  5. Natco Pharma

    World Rank (Jan-05-2024)
    6,025
    Market Cap (Jan-05-2024)
    1.819 Billion USD
    World Rank (Jul-30-2023)
    6,139
    Market Cap (Jul-30-2023)
    1.799 Billion USD
    World Rank (Dec-25-2022)
    7,464
    Market Cap (Dec-25-2022)
    1.219 Billion USD
    World Rank (Jan-07-2022)
    5,830
    Market Cap (Jan-07-2022)
    2.24 Billion USD
    Annual Revenue in USD
    243 Million USD
    Annual Net Income in USD
    21 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile
    Pharmaceutical company with headquarters is in Hyderabad, India.
  6. Genus

    World Rank (Jan-05-2024)
    6,032
    Market Cap (Jan-05-2024)
    1.815 Billion USD
    World Rank (Jul-30-2023)
    5,563
    Market Cap (Jul-30-2023)
    2.094 Billion USD
    World Rank (Dec-25-2022)
    4,834
    Market Cap (Dec-25-2022)
    2.378 Billion USD
    World Rank (Jan-07-2022)
    3,804
    Market Cap (Jan-07-2022)
    4.11 Billion USD
    Annual Revenue in USD
    676 Million USD
    Annual Net Income in USD
    55 Million USD
    Annual Results for Period Ending
    Jun-2022 ending year
    Headquarters Country
    Company Profile
    Genus is a Animal Genetics company. The company is a breed better pigs and cattle for farmers so that they can produce high quality meat and milk more efficiently and sustainably. The headquarters is in UK.
  7. Prokidney Corp.

    World Rank (Jan-05-2024)
    6,039
    Market Cap (Jan-05-2024)
    1.812 Billion USD
    World Rank (Jul-30-2023)
    4,581
    Market Cap (Jul-30-2023)
    2.807 Billion USD
    World Rank (Dec-25-2022)
    5,906
    Market Cap (Dec-25-2022)
    1.755 Billion USD
    Headquarters Country
    Company Profile

    ProKidney is a late clinical-stage biotech company focused on the development of a pioneering cell therapy candidate that aims to transform the treatment landscape for Chronic Kidney Disease using a patient’s own cells.

    The headquarters is in USA.

  8. Amneal Pharmaceuticals

    World Rank (Jan-05-2024)
    6,045
    Market Cap (Jan-05-2024)
    1.809 Billion USD
    World Rank (Jul-30-2023)
    8,910
    Market Cap (Jul-30-2023)
    0.965 Billion USD
    World Rank (Dec-25-2022)
    15,083
    Market Cap (Dec-25-2022)
    0.333 Billion USD
    World Rank (Jan-07-2022)
    11,500
    Market Cap (Jan-07-2022)
    0.69 Billion USD
    Annual Revenue in USD
    2,212 Million USD
    Annual Operating Income in USD
    188 Million USD
    Annual Net Income in USD
    -129 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Amneal Pharmaceuticals is an Integrated Specialty Pharmaceutical company. It is powered by a robust U.S. generics business and a growing branded business and focused on delivering outcomes that meet important medical needs, make quality medicines more accessible and more affordable and provide solutions for tomorrows health challenges. The headquarters is in USA.
  9. Inhibrx Inc.

    World Rank (Jan-05-2024)
    6,046
    Market Cap (Jan-05-2024)
    1.809 Billion USD
    World Rank (Jul-30-2023)
    7,998
    World Rank (Dec-25-2022)
    7,998
    Market Cap (Dec-25-2022)
    1.081 Billion USD
    World Rank (Jan-07-2022)
    8,138
    Market Cap (Jan-07-2022)
    1.29 Billion USD
    Annual Revenue in USD
    7,125 Million USD
    Annual Net Income in USD
    -81 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Inhibrx is a Clinical Stage Biotechnology company developed a diverse pipeline of therapeutic candidates specifically designed to leverage the power of core sdAb (single-domain antibody) platform and protein engineering expertise. The company annual revenue is 34.1 million USD and 80 employees as on 2020. The headquarters is in USA.

Share

Ads